-
Scenario: The 12-lead ECG shown above was obtained from a 72-year-old woman seen in the emergency department (ED) with new-onset chest discomfort. No prior ECGs were available for comparison. The tracing was interpreted as "showing no acute changes." Do you agree? What else do you see?
-
-
Managing chronic pain is a challenge for patients and clinicians alike, with 52% of chronic pain patients being treated solely by their primary care physician.1 Chronic myofascial pain affects 116 million American adults, which is more than heart disease, cancer, and diabetes combined.2
-
-
Medically self-sabotaging behavior encompasses a number of diverse phenomena that include factitious disorder, making medical situations worse on purpose, and preventing wounds from healing.
-
Beta-Blocker Use in Situations Other than Just Post-MI; Long-Term Sexual and Psychological Adverse Effects of Finasteride; Novel CV Risk Markers: How Much Cluck for the Buck?
-
-
After careful evaluation of all the published studies regarding the possible adverse effects of statin therapy, Jukema et al have concluded that there is no proven increased risk of cognitive decline or cancer development. However, there is a possible small increased risk for the development of type 2 diabetes mellitus.
-
A new androgen receptor antagonist has been approved for the treatment of late-stage prostate cancer. Enzalutamide was approved 3 months ahead of schedule due to a priority review by the FDA. The drug is comarketed by Astellas Pharma and Medivation as Xtandi.
-
The authors concluded that interruption of warfarin therapy in non-valvular atrial fibrillation patients increased the short-term risk of death or thromboembolism, especially during the first 90 days of treatment interruption.